Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Form 8.5 (EPT/RI) Idox PLC

8 Dec 2025 12:00

RNS Number : 6220K
Peel Hunt LLP
08 December 2025
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Peel Hunt LLP

(b) Name of offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Idox Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Idox Plc

(d) Date dealing undertaken:

5 December 2025

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Shares

Purchase

5,000

 

68.90 GBx

 

68.90 GBx

 

Ordinary Shares

Sale

0

 

0.00 GBx

 

0.00 GBx

 

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

Date of disclosure:

08 December 2025

Contact name:

Paul Crispin

Telephone number:

+44 (0) 20 7418 8900

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEREAXAPEDLSFEA
Date   Source Headline
19th Feb 20217:39 amRNSStatement re Possible Offer
19th Feb 20217:00 amRNSStatement re Possible Offer
3rd Feb 20217:00 amRNSAGM Date & Dividend Payment Schedule
2nd Feb 20217:00 amRNSFY20 Results
19th Jan 20214:05 pmRNSExercise of Share Options & Total Voting Rights
19th Jan 20217:00 amRNSNotice of Final Results
2nd Dec 20207:00 amRNSContract Win
2nd Dec 20207:00 amRNSExercise of Share Options and Total Voting Rights
26th Nov 202011:37 amRNSInvestor presentation
17th Nov 20207:00 amRNSYear End Trading Update
27th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
22nd Oct 20205:35 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSAppointment of Head of Professional Services
14th Oct 20205:45 pmRNSReplacement: Exercise of Share Options & TVR
14th Oct 202011:51 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSIdox Rebrand and Recent Progress with Idox Cloud
13th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
23rd Sep 20205:30 pmRNSHolding(s) in Company
28th Aug 20207:00 amRNSDirectorate Changes
25th Aug 20207:00 amRNSExercise of Share Options & Total Voting Rights
16th Jul 20207:00 amRNSExercise of Share Options & Total Voting Rights
8th Jul 20201:58 pmRNSHolding(s) in Company
19th Jun 20207:00 amRNSGrant of Options
15th Jun 20207:00 amRNSHalf-year Report
28th May 202011:18 amRNSResult of AGM
19th May 20207:00 amRNSHalf Year Trading Update
1st May 20207:42 amRNSPosting of Annual Report and Notice of AGM
28th Apr 20204:33 pmRNSHolding(s) in Company
20th Apr 20208:01 amRNSProgressive publishes new research
14th Apr 20207:01 amRNSDirectorate Change
14th Apr 20207:00 amRNSFinal Results
30th Mar 20204:36 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSNotice of Results Update
16th Mar 20207:00 amRNSTrading Update and Notice of Results update
7th Feb 202011:33 amRNSHolding(s) in Company
7th Feb 202011:29 amRNSNotice of Results
23rd Jan 20207:00 amRNSChange of Adviser and Notice of Results
22nd Jan 202012:44 pmRNSAIM Rule 17 Schedule Two (g) Update
17th Jan 202012:12 pmRNSDirectors' Dealings & Holdings in Company
3rd Jan 20207:00 amRNSDirectors' Dealings & Holdings in Company
24th Dec 201912:49 pmRNSDirectors' Dealings & Holdings in Company
19th Dec 20197:00 amRNSNew Banking Facilities
2nd Dec 20192:45 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:54 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:10 pmRNSHolding(s) in Company
27th Nov 20192:08 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSYear End Trading Update
3rd Oct 20192:09 pmRNSExercise of Share Options & Total Voting Rights
17th Sep 20193:03 pmRNSHolding(s) in Company
30th Aug 201910:02 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.